Given its pivotal role in DNA damage response, CHEK2 represents a potential therapeutic target in cancer treatment. Inhibitors of CHEK2 could be used to sensitize cancer cells to DNA-damaging agents, enhancing the efficacy of chemotherapy and radiotherapy. Additionally, restoring CHEK2 function in cells with defective DNA repair mechanisms could help in cancer prevention and treatment.
